![London Stock Exchange podcast artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts125/v4/e2/4b/48/e24b4861-8639-22f9-5f92-059f7e85c027/mza_7584990570493084045.jpg/100x100bb.jpg)
A Breath of Fresh Air in Lung Disease Treatment – Be Inspired
London Stock Exchange podcast
English - October 25, 2022 06:25 - 15 minutes - 21.7 MBManagement Business Technology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Driving Innovation in Transport Technology – Be Inspired
Next Episode: Addressing the stigma of mental health – Be Inspired
LSEG’s Rhiannon Main speaks to Bob Rauker, Belluscura’s Chief Executive Officer, to discuss how the MedTech company’s impressive growth in treating COPD and lung diseases with its next-generation oxygen enrichment technologies.
Having seen an oversubscribed IPO in 2021, the conversation highlights the company’s journey since its formation; from the first product launch, to FDA approval, continuing innovation, and how listing on AIM enabled a successful raise and has unlocked new growth potential.
To watch more from this series, head to lsegissuerservices.com/spark